Molecular genetics in IgA nephropathy

Nephron

Volumn 88, Issue 2, 2001, Pages 107-112

  Galla, John H ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Division of Nephrology and Hypertension   (United States)

Author keywords

Glomerulonephritis; Henoch Sch nlein purpura; IgA immune system; Immunoglobulin A nephropathy; Renal failure

Indexed keywords

COMPLEMENT COMPONENT C3; HLA ANTIGEN;

ALLOTYPE; ANAPHYLACTOID PURPURA; ARTICLE; CHRONIC KIDNEY FAILURE; DISEASE COURSE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MOLECULAR GENETICS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; GLOMERULONEPHRITIS, IGA; HUMANS;

EID: 0034961044     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045969     Document Type: Article

References (68)

1. Les dépôts intercapillaires d'IgA-IgG
2. Racial differences in the prevalence of IgA-associated nephropathies
3. Low incidence of IgA nephropathy in blacks
4. Genetics and evolution of human immunoglobulin A
5. Immunoglobulin A nephropathy in blacks and homozygosity for the genetic marker A2m
6. IgA nephropathy in blacks: Studies of IgA2 allotypes and clinical course
7. Immunological studies of IgA nephropathy: Familial and racial aspects
8. Glomérulites à dépôts d'IgA diffus dans le mesangium. Etude de 96 cas chez l'adulte
9. IgA nephropathy in HLA-identical siblings
10. Familial IgA nephropathy. Evidence for an inherited mechanism of disease
11. Genetic factors in primary IgA nephropathy
12. IgA nephropathy: Pros and cons for a familial disease
13. Familial IgA nephropathy
14. Strong association of HLA-DR4 with benign IgA nephropathy
15. Primary IgA glomerulonephritis and MHC revisited
16. HLA-DQ gene polymorphism in primary IgA nephropathy in three European populations
17. Familial clustering of IgA nephropathy: Further evidence in an Italian population
18. HLA B35 antigen as a prognostic factor
19. Immunogenetic aspects of primary IgA nephropathy
20. HLA class II typing and idiopathic IgA nephropathy (IgAN): DQB1*0301, a possible marker of unfavorable outcome
21. HLA associations in IgA nephropathy and focal and segmental glomerulosclerosis
22. Serum complement proteins in IgA nephropathy
23. IgA nephropathy
24. The complement system in IgA nephropathy and Henoch-Schoenlein purpura: Functional and genetic aspects
25. C4A deficiency and poor prognosis in patients with IgA nephropathy
26. Complement 4 locus II gene deletion and DQA1*0301 gene: Genetic risk factors for IgA nephropathy and Henoch-Schoenlein nephritis
27. Renal cortical complement C3 gene expression in IgA nephropathy
28. Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy
29. Polymorphism of the angiotensin converting enzyme gene and clinical aspects of IgA nephropathy
30. Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy
31. Angiotensin I-converting enzyme genotype significantly affects progression of IgA glomerulonephritis in an Italian population
32. No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis
33. Polymorphisms in angiotensin-converting enzyme gene and severity of renal disease in Henoch-Schoenlein patients
34. Deletion polymorphism of angiotensin converting enzyme predicts persistent proteinuria in Henoch-Schoenlein purpura nephritis
35. Association between angiotensin-converting enzyme gene polymorphism and failure of renoprotective therapy
36. Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy
37. Association of angiotensinogen gene T235 variant with progression of immunoglobulin A nephropathy in Caucasian patients
38. The renin-angiotensin system gene polymorphisms and clinicopathological correlations in IgA nephropathy
39. Association of IgA nephropathy with T-cell receptor constant alpha chain gene polymorphism
40. Association of a T-cell receptor constant alpha chain polymorphism with progression of IgA nephropathy in Japanese patients
41. Glomerular FcαR expression and disease activity in IgA nephropathy
42. Expression and physical association of Fc α receptor and Fc receptor γ chain in human mesangial cells
43. IgA-induced activation of human mesangial cells: Independent of FcαR1 (CD89)
44. Expression of mucosal γδ T cell receptor V region repertoire in patients with IgA nephropathy
45. Small bowel T cells, HLA class II antigen DR, and GroEL stress protein in IgA nephropathy
46. Relation of mesangial IgA glomerulonephritis to polymorphism of immunoglobulin heavy chain switch region
47. Immunoglobulin heavy chain switch region gene polymorphism in glomerulonephritis
48. Polymorphism of immunoglobulin heavy chain switch region gene in children with severe IgA nephropathy
49. A mesangium-predominant gene, megsin, is a new serpin upregulated in IgA nephropathy
50. Expression of megsin mRNA, a novel mesangium-predominant gene, in the renal tissues of various glomerular diseases
51. Effect of a polymorphism of endothelial cell nitric oxide synthase gene in Japanese patients with IgA nephropathy
52. Role of platelet-activating factor acetylhydrolase gene mutation in Japanese childhood IgA nephropathy
53. Increased mRNA expression of metalloproteinase-9 in peripheral blood monocytes from patients with immunoglobulin A nephropathy
54. Leucocyte beta-1,3 galactosyltransferase activity in IgA nephropathy
55. Receptor-mediated binding and uptake of immunoglobulin A by human liver
56. Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy
57. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG
58. Anti-α-galactosyl antibodies and immune complexes in children with Henoch-Schoenlein purpura or IgA nephropathy
59. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and anti-glycan antibodies
60. The nucleotide sequence of the IgA1 hinge region in IgA nephropathy
61. IgA1 glycosylation and the pathogenesis of IgA nephropathy
62. Animal models as a means to study IgA nephropathy
63. Spontaneous glomerular IgA deposition in ddY mice: An animal model of IgA nephritis
64. Evidence suggesting the involvement of hematopoietic stem cells in the pathogenesis of IgA nephropathy
65. Bone marrow transplantation attenuates murine IgA nephropathy: The role of a stem cell disorder
66. Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice